TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.

Bryan J Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.